Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Eva-Maria Grischke

6PUBLICATIONS

60CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental health

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jan 13, 2026

Electrochemotherapy as a symptom-oriented palliative treatment option: an exploratory single-center study in 15 patients with locally advanced or locoregionally recurrent vulvar carcinoma.

Eva-Maria Grischke, Felix Neis, Ernst Oberlechner

|Sep 11, 2025

Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.

Hans-Christian Kolberg, Johannes Schumacher, Ramona Erber

|Feb 22, 2023

De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.

Nadia Harbeck, Ulrike A Nitz, Matthias Christgen

|Nov 28, 2022

Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial.

Monika Graeser, Oleg Gluz, Claudia Biehl

|Jul 07, 2022

De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial.

Oleg Gluz, Ulrike Nitz, Cornelia Kolberg-Liedtke

|Jun 23, 2018

Pregnancy-associated breast cancer: maternal breast cancer survival over 10 years and obstetrical outcome at a university centre of women's health.

Elisabeth Simoes, Joachim Graf, Alexander N Sokolov

Pageof 1

Frequent Collaborators

3 joint publications

Nadia Harbeck

3 joint publications

Monika Graeser

3 joint publications

Oleg Gluz

3 joint publications

Claudia Schumacher

3 joint publications

Michael Braun

2 joint publications

Sherko Kümmel

2 joint publications

Jochem Potenberg

2 joint publications

Matthias Christgen

2 joint publications

Sara Y Brucker

2 joint publications

Bahriye Aktas

Frequent Collaborators

3 joint publications

Nadia Harbeck

3 joint publications

Monika Graeser

3 joint publications

Oleg Gluz

3 joint publications

Claudia Schumacher

Top Related Videos

Electrochemotherapy of Tumours

Electrochemotherapy of Tumours

Published on : Dec 15, 2008

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos

Top Related Videos

Electrochemotherapy of Tumours

Electrochemotherapy of Tumours

Published on : Dec 15, 2008

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos